It has also been reported that triptolide can significantly reduce the expression of NRF2, leading to corresponding inhibition of NRF2 downstream targets GPX4 and SLC7A11, and finally promoting ferroptosis in cervical cancer cells [152]. Here, GPX4 is linked to cervical carcinoma.